Deutsche Bank
LUMO

Deutsche Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Deutsche Bank’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-780
Closed -$10K – 5345
2019
Q2 		$10K Sell
780
-3,173
-80% -$47.9K ﹤0.01% 4987
2019
Q1 		$68K Sell
3,953
-291
-7% -$4.34K ﹤0.01% 4457
2018
Q4 		$56K Sell
4,244
-4,641
-52% -$81.7K ﹤0.01% 4441
2018
Q3 		$191K Sell
8,885
-1,698
-16% -$51.6K ﹤0.01% 4255
2018
Q2 		$454K Sell
10,583
-28,660
-73% -$1.31M ﹤0.01% 3895
2018
Q1 		$2.56M Buy
39,243
+20,076
+105% +$1.42M ﹤0.01% 2702
2017
Q4 		$1.4M Buy
19,167
+8,982
+88% +$743K ﹤0.01% 2973
2017
Q3 		$932K Sell
10,185
-22,238
-69% -$1.71M ﹤0.01% 3074
2017
Q2 		$2.14M Buy
32,423
+16,097
+99% +$1.99M ﹤0.01% 2520
2017
Q1 		$3.54M Sell
16,326
-4,099
-20% -$586K ﹤0.01% 1888
2016
Q4 		$1.89M Sell
20,425
-15,921
-44% -$1.79M ﹤0.01% 2296
2016
Q3 		$4.91M Sell
36,346
-1,241
-3% -$123K ﹤0.01% 1738
2016
Q2 		$3.81M Buy
37,587
+6,865
+22% +$851K ﹤0.01% 1950
2016
Q1 		$5.03M Buy
30,722
+23,881
+349% +$4.84M ﹤0.01% 1728
2015
Q4 		$2.24M Sell
6,841
-12,798
-65% -$4.17M ﹤0.01% 2354
2015
Q3 		$6.33M Buy
19,639
+18,760
+2,134% +$8.24M ﹤0.01% 1622
2015
Q2 		$349K Sell
879
-78
-8% -$33.1K ﹤0.01% 3606
2015
Q1 		$469K Buy
957
+119
+14% +$46.1K ﹤0.01% 3326
2014
Q4 		$299K Sell
838
-405
-33% -$121K ﹤0.01% 4058
2014
Q3 		$238K Buy
1,243
+1,232
+11,200% +$271K ﹤0.01% 3972
2014
Q2 		$2K Sell
11
-1,601
-99% -$326K ﹤0.01% 5732
2014
Q1 		$411K Buy
1,612
+337
+26% +$103K ﹤0.01% 3459
2013
Q4 		$252K Sell
1,275
-4,873
-79% -$867K ﹤0.01% 3561
2013
Q3 		$1.04M Sell
6,148
-1,710
-22% -$275K ﹤0.01% 2951
2013
Q2 		$1.39M Buy
+7,858
New +$1.11M ﹤0.01% 2460

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank's LUMO Position: Q3 2019 in Review

Deutsche Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 780 shares — an estimated $10K sold.

Deutsche Bank first reported a position in LUMO in Q2 2013 and held it in 25 quarters. The position peaked at $6.33M in Q3 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

  • Deutsche Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Deutsche Bank sold 780 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $10K.
  • Deutsche Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 25 quarters.
  • Deutsche Bank's Lumos Pharma, Inc. Common Stock position peaked at $6.33M in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.